BRIA

Latest SEC Filings & News for BRIA

2 most recent filings and news items mentioning BRIA. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/BRIA/news?limit=20"

Pull BRIA filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

BriaPro Therapeutics reports $299,950 in cash for interim period.

BriaPro Therapeutics Corp. filed unaudited interim financial statements for the period ended April 30, 2026, showing a substantial increase in total assets. The filing highlights a significant improvement in liquidity to approximately $300,000 in cash and cash equivalents, contra

View filing at SEC.gov →

BriaCell issues placement agent warrants exercisable from June 2026

BriaCell Therapeutics filed a warrant agreement allowing placement agents to purchase common shares starting June 2, 2026, expiring five years later per FINRA rules. The warrant issuance is typical financing activity for biotech companies seeking to incentivize capital raising in

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.